Sit Investment Associates Inc. cut its position in Stericycle Inc. (NASDAQ:SRCL) by 25.3% during the second quarter, Holdings Channel reports. The institutional investor owned 22,025 shares of the company’s stock after selling 7,475 shares during the period. Sit Investment Associates Inc.’s holdings in Stericycle were worth $2,293,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the company. Prudential Financial Inc. increased its stake in Stericycle by 3.0% in the first quarter. Prudential Financial Inc. now owns 109,323 shares of the company’s stock worth $13,795,000 after buying an additional 3,225 shares in the last quarter. BlackRock Group LTD raised its stake in shares of Stericycle by 12.4% in the first quarter. BlackRock Group LTD now owns 878,113 shares of the company’s stock worth $110,810,000 after buying an additional 96,910 shares during the period. BlackRock Fund Advisors raised its stake in shares of Stericycle by 6.4% in the first quarter. BlackRock Fund Advisors now owns 1,707,528 shares of the company’s stock worth $215,473,000 after buying an additional 103,024 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in shares of Stericycle by 0.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,289,722 shares of the company’s stock worth $288,940,000 after buying an additional 19,063 shares during the period. Finally, C M Bidwell & Associates Ltd. bought a new stake in shares of Stericycle during the first quarter worth about $300,000. 92.72% of the stock is currently owned by institutional investors.
Stericycle Inc. (NASDAQ:SRCL) traded up 2.2638% during mid-day trading on Monday, hitting $76.8001. The stock had a trading volume of 723,648 shares. Stericycle Inc. has a 52 week low of $74.95 and a 52 week high of $151.57. The company has a market capitalization of $6.53 billion, a P/E ratio of 27.0328 and a beta of 0.21. The stock’s 50-day moving average is $81.55 and its 200 day moving average is $99.23.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm had revenue of $891.60 million for the quarter, compared to the consensus estimate of $910.29 million. During the same quarter last year, the business posted $1.14 EPS. The company’s revenue for the quarter was up 24.6% on a year-over-year basis. Equities analysts forecast that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
A number of equities research analysts have recently issued reports on SRCL shares. Zacks Investment Research raised Stericycle from a “hold” rating to a “buy” rating and set a $119.00 target price on the stock in a research report on Thursday, July 21st. Royal Bank Of Canada cut their target price on Stericycle from $89.00 to $77.00 and set an “underperform” rating on the stock in a research report on Monday, September 19th. RBC Capital Markets reaffirmed an “underperform” rating and set a $77.00 target price (down from $89.00) on shares of Stericycle in a research report on Monday, September 19th. Jefferies Group reaffirmed a “buy” rating and set a $125.00 target price on shares of Stericycle in a research report on Tuesday, August 23rd. Finally, Northcoast Research lowered Stericycle from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 20th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $103.54.
In other Stericycle news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now owns 10,188 shares of the company’s stock, valued at approximately $871,074. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by company insiders.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.